alanylglutamine has been researched along with Intestinal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, A; Li, J; Shan, A; Wang, J; Yang, L | 1 |
| Bamba, T; Fujiyama, Y; Satoh, J; Tsujikawa, T | 1 |
2 other study(ies) available for alanylglutamine and Intestinal Diseases
| Article | Year |
|---|---|
Protective effect of glutamine and alanyl-glutamine against zearalenone-induced intestinal epithelial barrier dysfunction in IPEC-J2 cells.
Topics: Animals; Apoptosis; Cell Line; Dipeptides; Epithelial Cells; Estrogens, Non-Steroidal; Glutamine; Intestinal Diseases; Intestinal Mucosa; Intestines; Permeability; Protective Agents; Reactive Oxygen Species; Zearalenone | 2021 |
Nutritional benefits of enteral alanyl-glutamine supplementation on rat small intestinal damage induced by cyclophosphamide.
Topics: Alanine; Amino Acid Transport Systems; Animals; Antineoplastic Agents, Alkylating; Biomarkers; Body Weight; Cadherins; Carrier Proteins; Cyclophosphamide; Dietary Supplements; Dipeptides; Disease Models, Animal; Enteral Nutrition; Glutamine; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Male; Membrane Transport Proteins; Rats; Rats, Sprague-Dawley; RNA, Messenger; Time Factors | 2003 |